Dimension Inx names thought leaders in regenerative medicine to inaugural board of scientific and business advisors

CHICAGO, Illinois, USA – August 5, 2021 – Dimension Inx, a regenerative biomaterials company, announces the formation of its Advisory Board, adding recognized expert in regenerative medicine, 3D-printing, and cell biology to its growing team.

The inaugural group includes Andy Christensen, a pioneer in the medical 3D-printing industry; Monica Laronda, Ph.D., the company’s chief collaborator in engineering a bioprosthetic ovary; Derek Steinbacher, D.M.D., M.D., a forward-thinking surgeon and specialist in craniomaxillofacial surgery; and Doris Taylor, Ph.D., a visionary expert in regenerative therapies.

Dimension Inx develops regenerative medical products, leveraging its next-gen biomaterials platform to create 3D-printed bioscaffolds for therapeutic use. These bioscaffolds are comprised of key ingredients in a specific architecture that catalyze tissue repair upon implantation in the body. The company uniquely focuses on designing tissue microenvironments that provide necessary signals for healthy cell growth and development.

Andy Christensen has spent his entire career developing and expanding the medical applications of additive manufacturing, also known as 3D-printing. He was the founder and president of Medical Modeling Inc., a medical device-focused 3D-printing service bureau acquired by 3D Systems in 2014. He is currently an adjunct professor at the University of Ottawa, in the leadership of the RSNA Special Interest Group on 3D Printing, and advisor and board member to a number of enterprises in the healthcare sector.

Monica Laronda, Ph.D., is the Director of Basic and Translational Research for the Fertility & Hormone Preservation & Restoration Program at Ann & Robert H. Lurie Children's Hospital of Chicago and Assistant Professor at Northwestern University. She is a long-time collaborator of Dimension Inx’s scientific founders, working together to develop a bioprosthetic ovary that will support systemic hormone function and restore fertility. Results of their collaboration were published in Nature Communications in 2017, describing a 3D-printed ovarian implant that fully restored ovarian function in mice and led to the live birth of mouse pups.

Derek Steinbacher, D.M.D., M.D., is Chief of Oral and Maxillofacial Surgery, Chief of Dentistry, and Director of Craniofacial Surgery at the Yale School of Medicine. He is a board-certified Plastic and Reconstructive surgeon, specializing in cleft, craniofacial, and maxillofacial surgery. His research encompasses tissue engineering and regeneration, distraction osteogenesis, and 3D analysis and planning. Dr. Steinbacher’s guidance has been instrumental in the development of Dimension Inx’s lead product for maxillofacial bone reconstruction.

Doris Taylor, Ph.D., DSc (H), is a pioneer in cardiovascular regenerative medicine, credited with a number of important scientific breakthroughs related to cell and gene therapy, stem cell biology, and tissue engineering. She has held appointments at Duke University Medical Center, University of Minnesota Medical School, Texas Heart Institute, Texas A&M University, and Rice University. Doris is also an accomplished entrepreneur and co-founder of MiroMatrix Medical (Nasdaq: MIRO).

“We are thrilled that this diverse group of exceptional thinkers and doers is joining us on our mission to create microenvironments for healing,” said Ramille Shah, Ph.D., co-founder and Chief Scientific Officer. “Our advisors importantly bring an intimate understanding of patient and surgeon needs, scientific rigor, and a track record of commercial success.”

+ About Dimension Inx

Dimension Inx is the architect of regenerative microenvironments. Our materials give the body a blueprint to heal itself.

We take a materials-centric approach to solving patient needs. Our bioactive materials and structures emulate the body’s microenvironment to elicit a regenerative response. Our patented biomaterials platform and additive manufacturing process are highly adaptable to enable design for biofunctionality and manufacturability. We work with leading product and R&D organizations to co-create a wide variety of clinical applications and accelerate the development of new regenerative solutions.

Dimension Inx is proudly based in Chicago, Illinois.  To learn more about our team and our technology, please visit www.dimensioninx.com.